1. Home
  2. BDL vs MDXH Comparison

BDL vs MDXH Comparison

Compare BDL & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flanigan's Enterprises Inc.

BDL

Flanigan's Enterprises Inc.

N/A

Current Price

$46.29

Market Cap

84.6M

ML Signal

N/A

Logo MDxHealth SA

MDXH

MDxHealth SA

N/A

Current Price

$0.59

Market Cap

68.7M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
BDL
MDXH
Founded
1959
2003
Country
United States
Belgium
Employees
N/A
N/A
Industry
Restaurants
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
84.6M
68.7M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
BDL
MDXH
Price
$46.29
$0.59
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
★ $1.80
AVG Volume (30 Days)
21.4K
★ 200.4K
Earning Date
08-12-2026
11-12-2026
Dividend Yield
★ 1.29%
N/A
EPS Growth
N/A
N/A
EPS
★ 3.09
N/A
Revenue
★ $205,248,000.00
N/A
Revenue This Year
N/A
$5.40
Revenue Next Year
N/A
$12.92
P/E Ratio
$15.01
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$27.55
$0.40
52 Week High
$52.12
$5.33

Technical Indicators

Market Signals
Indicator
BDL
MDXH
Relative Strength Index (RSI) 54.14 44.04
Support Level $29.36 $0.51
Resistance Level $47.99 $0.64
Average True Range (ATR) 1.91 0.04
MACD 0.16 -0.00
Stochastic Oscillator 73.78 51.98

Price Performance

Historical Comparison
BDL
MDXH

About BDL Flanigan's Enterprises Inc.

Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: